Literature DB >> 18418853

Adult granulosa cell tumor of the ovary: fine-needle-aspiration cytology of 10 cases and review of literature.

Sarfraz Ali1, Paolo Gattuso, Allison Howard, Marina B Mosunjac, Momin T Siddiqui.   

Abstract

Adult granulosa cell tumor (GCT) of the ovary is mostly diagnosed in postmenopausal women. They typically secrete estrogen, which stimulates the endometrium to proliferate and cause abnormal bleeding. This study reviews the cytologic features of adult GCT of the ovary diagnosed by fine-needle aspiration (FNA). We reviewed slides from ten cases diagnosed by CT guided FNA from 1995 to 2007 at our institutions. Smears were stained with Diff-Quik and Papanicolaou stains. Patient's history and histologic diagnosis were also available and reviewed for all cases. The patients ranged in age from 39 to 83 yr. All 10 cases were hypercellular with both large and small overlapping cell clusters and individual cells. The cytologic features identified included: naked nuclei (10/10 cases), Call-Exner bodies (7/10 cases), blood vessels with prominent perivascular tumor cell growth (4/10 cases), spindle-shaped hyperchromatic stromal cells within cellular clusters (6/10 cases), mixed inflammation (3/10 cases), tumor cell necrosis (1/10 cases), and prominent metachromatic stroma seen in association with blood vessels (1/10 cases). Moderate to scant delicate cytoplasm was also seen (10/10 cases). Small, punctuate cytoplasmic vacuoles were also noted (7/10 cases) and were occasionally prominent (3/10 cases). In general nuclear to cytoplasmic ratios were high although lower than those typically seen in a lymphoma or small-cell carcinoma. Nuclei were generally centrally located although eccentrically located nuclei were consistently seen in a minority of cells. Nuclei were monotonous in size showing slightly convoluted (occasional rentiform and fetiform nuclei) to polygonal outlines. Prominent, central nucleoli were also seen (4/10 cases). Nuclear grooves were also seen (9/10 cases). No atypical mitotic activity was identified in any of the 10 cases (0/10 cases). In summary, the above cytologic features can also help in the cytologic diagnosis of adult GCTs.

Entities:  

Mesh:

Year:  2008        PMID: 18418853     DOI: 10.1002/dc.20798

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  7 in total

1.  FOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.

Authors:  Zhilin Liu; Yi A Ren; Stephanie A Pangas; Jaye Adams; Wei Zhou; Diego H Castrillon; Dagmar Wilhelm; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2015-06-10

2.  Cytologic features of sex cord-stromal tumors in women.

Authors:  Liz N Edmund; Abeer M Salama; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2021-08-19       Impact factor: 4.264

3.  Delayed menopause due to ovarian granulosa cell tumour.

Authors:  Neetha Vyas M; Lakshmi Manjeera; Supriya Rai
Journal:  J Clin Diagn Res       Date:  2013-10-05

4.  Intraoperative Cytology of Ovarian Neoplasms with an Attempt to Grade Epithelial Tumors.

Authors:  Sangita Bohara; Shyama Jain; Nita Khurana; Darilin M Shangpliang; Swapnil Agarwal; Gauri Gandhi
Journal:  J Cytol       Date:  2018 Jan-Mar       Impact factor: 1.000

5.  The multifaceted granulosa cell tumours-myths and realities: a review.

Authors:  Rani Kanthan; Jenna-Lynn Senger; Selliah Kanthan
Journal:  ISRN Obstet Gynecol       Date:  2012-09-13

6.  Peritoneal washing cytology in an adult granulosa cell tumor: A case report and review of literature.

Authors:  Alev O Atilgan; Merih Tepeoglu; Ozlem Ozen; Banu Bilezikçi
Journal:  J Cytol       Date:  2013-01       Impact factor: 1.000

Review 7.  Anti-müllerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development.

Authors:  Marie Lindhardt Johansen; Casper P Hagen; Trine Holm Johannsen; Katharina M Main; Jean-Yves Picard; Anne Jørgensen; Ewa Rajpert-De Meyts; Anders Juul
Journal:  Int J Endocrinol       Date:  2013-12-03       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.